Source: PR Newswire

Press Release: Innovent Biologics : Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Read full article »
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
Michael Yu's photo - Chairman & CEO of Innovent Biologics

Chairman & CEO

Michael Yu

CEO Approval Rating

90/100

Read more